Latest Safety News

Noxopharm’s Sofra™ technology shows promising results in collaboration with US biotech Tezcat Biosciences, advancing targeted drug delivery for cancer and inflammatory diseases.

Race Oncology’s Phase 1b/2 trial of RC110 bisantrene for relapsed or refractory acute myeloid leukemia has demonstrated a 40% response rate, exceeding expectations and offering new hope for difficult-to-treat patients.

Element 25 Limited is advancing its Butcherbird Manganese Mine expansion in Western Australia alongside a new US-based refinery, backed by strong financing and partnerships with major automakers for EV battery-grade manganese supply.

Activeport Group Ltd has announced a fully underwritten rights issue to raise up to $2.5 million, offering shareholders discounted shares and free options to accelerate growth initiatives.

Nyrada Inc. has raised $8.25 million through a strategic placement to fund its upcoming Phase IIa clinical trial of Xolatryp for acute myocardial infarction, positioning the company for a pivotal year ahead.

Chimeric Therapeutics has progressed its CHM CDH17 CAR-T cell therapy to dose level 2 in its Phase 1/2 trial, showing promising early anti-tumor activity and a strong safety profile in gastrointestinal and neuroendocrine cancers.

Beach Energy has reported a robust FY25 performance marked by significant production growth, record free cash flow, and strategic progress on key projects like the Waitsia Gas Plant and Moomba CCS. The company’s disciplined cost management and gas marketing strategy underpin a confident outlook for FY26.

Beach Energy reported robust FY25 results marked by significant cost reductions, increased production, and record dividends, while advancing key projects like the Waitsia Gas Plant and Moomba CCS.

dorsaVi Ltd is expanding its RRAM technology evaluation to next-generation robotics, aiming to deliver sub-millisecond reflexes that could revolutionize safety and dexterity in collaborative robots and wearables.

Perseus Mining announces the retirement of long-serving CEO Jeff Quartermaine, who transformed the company into an ASX100 gold producer. Craig Jones, former Newcrest COO, will take the helm in October 2025, steering Perseus through its next growth phase.

Galan Lithium has formalised a $20 million strategic investment agreement with The Clean Elements Fund to fund the initial phase of its Hombre Muerto West lithium project in Argentina, aiming for production in early 2026.

Bellevue Gold Limited outlines a robust FY26 production outlook with potential to exceed guidance, supported by an updated 3.1 million ounce resource and 1.3 million ounce reserve. The company advances feasibility on a paste plant to enhance long-term economics.